A small Yale study on migraine
Ten adults with migraine took part in a double-blind crossover study, where each person received both psilocybin and a placebo on separate occasions. In the two weeks after a single session, weekly migraine days dropped by about 1.65 after psilocybin and by about 0.15 after placebo.
Worth knowing
Ten people is a pilot. Everyone received placebo first and psilocybin second, which makes order effects possible. It is a reason to run a larger study, not a result to lean on.
Neurotherapeutics, 2020
Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin →